DA ROS, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.975
AS - Asia 940
EU - Europa 848
AF - Africa 162
SA - Sud America 122
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 4.076
Nazione #
US - Stati Uniti d'America 1.872
SG - Singapore 421
IT - Italia 382
CN - Cina 202
HK - Hong Kong 82
NL - Olanda 76
BR - Brasile 63
DE - Germania 58
VN - Vietnam 53
FI - Finlandia 52
SE - Svezia 43
PL - Polonia 39
GB - Regno Unito 23
IN - India 22
FR - Francia 20
RU - Federazione Russa 20
CA - Canada 16
TR - Turchia 13
ZA - Sudafrica 12
AR - Argentina 11
MX - Messico 11
UZ - Uzbekistan 10
AU - Australia 9
BJ - Benin 9
IE - Irlanda 9
JP - Giappone 9
PY - Paraguay 9
AT - Austria 8
BO - Bolivia 8
IL - Israele 8
IR - Iran 8
MK - Macedonia 8
PE - Perù 8
BB - Barbados 7
CH - Svizzera 7
DO - Repubblica Dominicana 7
IS - Islanda 7
JM - Giamaica 7
KR - Corea 7
RW - Ruanda 7
BE - Belgio 6
CM - Camerun 6
CW - ???statistics.table.value.countryCode.CW??? 6
DK - Danimarca 6
EG - Egitto 6
ES - Italia 6
HU - Ungheria 6
ID - Indonesia 6
IQ - Iraq 6
LC - Santa Lucia 6
NG - Nigeria 6
PA - Panama 6
PR - Porto Rico 6
RS - Serbia 6
SA - Arabia Saudita 6
SI - Slovenia 6
SO - Somalia 6
UA - Ucraina 6
XK - ???statistics.table.value.countryCode.XK??? 6
AL - Albania 5
BD - Bangladesh 5
CG - Congo 5
CL - Cile 5
CR - Costa Rica 5
DZ - Algeria 5
EC - Ecuador 5
EE - Estonia 5
GE - Georgia 5
GH - Ghana 5
HR - Croazia 5
HT - Haiti 5
JO - Giordania 5
KE - Kenya 5
KZ - Kazakistan 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
LV - Lettonia 5
MA - Marocco 5
MD - Moldavia 5
MR - Mauritania 5
NE - Niger 5
PT - Portogallo 5
TH - Thailandia 5
TJ - Tagikistan 5
TZ - Tanzania 5
YT - Mayotte 5
AD - Andorra 4
AE - Emirati Arabi Uniti 4
BW - Botswana 4
CI - Costa d'Avorio 4
CO - Colombia 4
CV - Capo Verde 4
GA - Gabon 4
GN - Guinea 4
MN - Mongolia 4
MQ - Martinica 4
MY - Malesia 4
MZ - Mozambico 4
NP - Nepal 4
PS - Palestinian Territory 4
Totale 3.948
Città #
Ashburn 268
Singapore 242
Fairfield 178
Chandler 166
Woodbridge 154
Houston 96
Ann Arbor 90
Santa Clara 90
San Jose 81
Hong Kong 73
Seattle 71
Wilmington 69
Cambridge 67
Beijing 62
Los Angeles 32
Milan 31
Boardman 30
Bytom 28
Helsinki 27
Des Moines 24
Medford 22
Princeton 22
Rome 18
Dong Ket 16
Guangzhou 15
New York 15
Roxbury 15
San Diego 15
Padova 14
Hanoi 12
Munich 12
Turin 10
Turku 10
Council Bluffs 9
Florence 9
Ho Chi Minh City 9
Nanjing 9
Naples 9
Tashkent 9
Buffalo 8
Cotonou 8
Warsaw 8
Kigali 7
Lima 7
Redondo Beach 7
Stockholm 7
Atlanta 6
Boston 6
Bridgetown 6
Brooklyn 6
Cagliari 6
Castries 6
Dublin 6
Johannesburg 6
Skopje 6
São Paulo 6
Accra 5
Amman 5
Bari 5
Bologna 5
Chicago 5
Dushanbe 5
Falls Church 5
Hefei 5
Lagos 5
Ljubljana 5
Marigliano 5
Montreal 5
Mumbai 5
Niamey 5
North Bergen 5
Nouakchott 5
Padua 5
Panama City 5
Pristina 5
Riga 5
San Juan 5
Shanghai 5
Shenyang 5
Tokyo 5
Verona 5
Willemstad 5
Almaty 4
Andorra la Vella 4
Ankara 4
Belgrade 4
Cochabamba 4
Conakry 4
Dar es Salaam 4
Escanaba 4
Fisciano 4
Giugliano in Campania 4
Harare 4
Hargeisa 4
Kingston 4
Libreville 4
London 4
Lucca 4
Maputo 4
Nairobi 4
Totale 2.443
Nome #
Oncogene c-KIT: promoter region and downstream effectors as novel therapeutic targets 593
Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models 233
DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma 213
G-Quadruplex Modulation of SP1 Functional Binding Sites at the KIT Proximal Promoter 195
Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease? 188
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 186
Indenocinnoline derivatives as G-quadruplex binders, topoisomerase IIα inhibitors and antiproliferative agents 184
G-rich sequences within proto-oncogene KIT promoter region as targets for anticancer therapy. 183
Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies 175
Impairment of c-kit expression in human cancer cell lines by a novel pharmacophoric unit selected for the recognition of the proto-oncogene KIT promotorial region. 173
DNA targeting by cationic porphyrin-ruthenium(II) conjugates 172
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach. 168
DNA elements for constitutive androstane receptor- and pregnane X receptor-mediated regulation of bovine CYP3A28 gene 168
Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach Investigation 157
Targeting canine c-KIT promoter by a candidate DNA G-quadruplex ligand 155
Targeting canine kit promoter by candidate DNA G-quadruplex ligands 151
A G-quadruplex binding compound down-regulates KIT, BCL2 and PDGFRβ expression in human gastric carcinoma cell line 146
Factors underlying the increase in carotid intima-media thickness in borderline hypertensives 146
Targeting Canine KIT Promoter by a Candidate DNA G-quadruplex Ligand 145
Evaluation of epigenetic mechanisms regulating HOXD10, FGFR2 and ITIH5 gene expression in canine B-cell lymphoma: an in vitro approach. 116
Characterization of the promoter region of the proto-oncogene c-kit in canine mast cell tumour 103
Characterization of the promoter region of the proto-oncogene c-Kit in canine mast cell tumour 99
CONFIRMATORY STUDIES ON THE TRANSCRIPTIONAL REGULATION OF BOVINE CYP3A28 GENE 69
Totale 4.118
Categoria #
all - tutte 11.547
article - articoli 7.031
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.578


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 31 13 25 38 26 21
2021/2022286 2 47 25 18 12 30 17 24 6 6 28 71
2022/2023306 52 48 1 47 35 33 4 15 40 6 21 4
2023/2024203 3 19 28 10 24 14 16 28 6 21 14 20
2024/2025924 15 50 49 39 135 57 67 77 91 35 125 184
2025/20261.546 175 157 305 387 257 164 101 0 0 0 0 0
Totale 4.118